Economic Times | DIPP may seek information from DCGI to manufacture generic version of ... Economic Times Indian companies have already developed biological products such as rituximab and pegylated interferon. There are several manufacturers who have trastuzumab in the pipeline as well," said Leena Menghaney of Medecins Sans Frontieres, an international ... |
